BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Acasti Pharma Reports Third Quarter FY 2018 Financial Results

  Acasti Pharma today announced its operating and financial results for the quarter ended December 31, 2017, which is the third quarter of Acasti’s fiscal year 2018.

  February 13, 2018

   · 

  10 min read
• Business

  GC Pharma and Lee’s Pharm Enter Into China Licensing Agreement to Develop and Commercialise GCC-4401C, an Investigational Anticoagulant

  Under the terms of the agreement, Lee’s Pharm receives exclusive rights to develop and commercialise the anticoagulant for the greater China and South East Asian market.

  February 13, 2018

   · 

  3 min read
• Deals

  Vaxart, Inc. Closes Merger with Aviragen Therapeutics, Inc.

  In connection with the merger, Aviragen Therapeutics, Inc. changed its name to Vaxart, Inc. and effected a 1-for-11 reverse split of its common stock.

  February 13, 2018

   · 

  3 min read
• Okayama University Research: Cell Membrane as Material for Bone Formation

  In a first study, the researchers observed that chondrocytes burst near the mineralized area, which they suggest might be a space-making mechanism for mineral expansion.

  February 13, 2018

   · 

  5 min read
• Drug Development

  Reata Announces Improvements in Kidney Function With Bardoxolone Methyl Maintained for Two Years in PAH Patients From LARIAT Trial

  The two-year duration of sustained eGFR improvement in LARIAT is twice as long as Reata has previously reported for bardoxolone.

  February 13, 2018

   · 

  8 min read
• Drug Development

  Actinium Announces Submission of IND For Actimab-A in Combination With CLAG-M for Patients with Relapsed or Refractory AML

  The planned Phase 1 trial studying Actimab-A in combination with CLAG-M will be an investigator initiated trial conducted at the Medical College of Wisconsin in a Phase 1, dose escalation study.

  February 13, 2018

   · 

  7 min read
• Business

  Supernus to Host Fourth Quarter and Full Year 2017 Earnings Conference Call

  The Company expects to report the financial results for the fourth quarter and full year of 2017 after 5:00 PM ET on Tuesday, February 27, 2018.

  February 13, 2018

   · 

  1 min read
• Business

  Dova Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results on February 15, 2018

  To participate on the live call, please dial 866-550-8145 (domestic) or +1-430-775-1344 (international) and provide the conference ID 7796295 five to 10 minutes before the start of the call.

  February 13, 2018

   · 

  1 min read
• Affimed Announces Proposed Public Offering of Common Stock

  All of the shares in the offering will be sold by Affimed.

  February 13, 2018

   · 

  3 min read
• Drug Development

  American Society for Radiation Oncology Release: Cabozantinib Shows Significant Activity in the First Line for Differentiated Thyroid Cancer

  Thirty-four of 35 patients in the trial experienced a reduction in tumor size following treatment with the targeted kinase inhibitor.

  February 13, 2018

   · 

  7 min read